Oliver Chen, TD Cowen senior retail analyst, joins 'Fast Money' to talk what to expect out of Target results tomorrow.

Mechanics Agree These Are the 2 Most Reliable Cars You Can Buy ...

KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and ...

Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1 bispecific antibody in development for treating solid ...

Investment bank TD Cowen expressed skepticism about the plan, calling it "uncoordinated" and lacking clarity on funding.

Well, welcome to the 45th Annual TD Cowen Healthcare Conference. I'm Dan Brennan, follow Tools and Diagnostics. Really pleased to be joined on stage here with Marc Casper, Chairman and President of ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ET ...

As biopharma players continue to parse out what the second Trump Administration means for the industry, Pfizer CEO Albert ...

Canada's oilfield drilling and services sector is already showing signs of slowing due to U.S. President Donald Trump's ...

In a report released yesterday, Stacy Ku from TD Cowen maintained a Buy rating on Astria Therapeutics (ATXS – Research Report), with a price ...

NetApp (NASDAQ:NTAP – Free Report) had its price target cut by TD Cowen from $160.00 to $130.00 in a research report released ...

Bloom Energy (NYSE:BE – Free Report) had its price target lifted by TD Cowen from $13.00 to $20.00 in a report released on Friday morning, MarketBeat.com reports. TD Cowen currently has a hold rating ...